You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Spain

May 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Economy fears a new recession

2011 did not bring the recovery as expected and in the last quarter of the year the Spanish economy recorded a negative growth rate. The poor economic situation has limited the performance of the consumer health market with sales only recording a marginal growth. Spaniards who are increasingly worried about the possibility of losing their jobs are reducing their expenditure on non-essential goods and activities. As a result of this growing tendency, there was a shift in consumption from OTC to prescription, reimbursed products, which contain the same active ingredient.

New laws in the pipeline

In 2011, the government announced a new change in the Spanish national health system with a change in the way doctors prescribe. From November 2011, doctors will have to prescribe by active ingredient and not by a brand. Chemists will also have to give patients the cheapest products with the same active ingredient. This is resulting in a drop in unit prices of semi-ethical products and hence damaging the performance of OTC products as their prices are even higher now when compared to reimbursed ones. Moreover, in 2012 a new law on the reference price system is expected be passed in order to reduce the medicine prices to the minimum as the Spanish Health Ministry stated. Lastly, the new ban on smoking came into force in January 2011, which is expected to boost the sales of NRT smoking cessation aids.

McNeil retains leadership of consumer health

McNeil Iberica SLU, the Spanish subsidiary of Johnson & Johnson Inc, continued to lead Spanish consumer health in 2011. The company, which was the result of the acquisition by Johnson & Johnson of Spanish laboratory Abelló, and the consumer division of Pfizer, reshuffled player rankings in the local consumer health landscape, which remains characterised by the high level of fragmentation with more than 100 active companies.

Grocery retailers consolidate trends

Consumer price-sensitivity increased, with growing demand for cheaper off-trade products, and as a consequence, the penetration of private label continued to grow in 2011. This was especially the case in categories such as wound care, sports nutrition, vitamins and dietary supplements or weight management. Moreover leading retail chains such as Mercadona and Carrefour reduced the space dedicated to branded references which also supported the growth of private label.

Meanwhile direct sales also benefited from the crisis as a number of Spaniards have become agents for these companies in order to earn extra money, which evidently benefited sales.

Slow movement going forward

Although the Spanish economy resisted a deeper recession in 2010, there were two variables which are set to affect the recovery over the forecast period. First, the high level of public deficit which has resulted in the government taking measures which are cutting down the average disposable income- such as the increase in taxes or the drop of public servants wage. Second, the rising level of unemployment will result in Spaniards saving more instead of spending. As a result, if the Spanish government does not implement any policies that prevent a worsening of this situation, the substitution of OTC products for reimbursed ones will drag down the performance of Spanish consumer health over the forecast period.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Spain with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Spain, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Spain for free:

The Consumer Health in Spain market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Spain?
  • What are the major brands in Spain?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Spain - Industry Overview

EXECUTIVE SUMMARY

Economy fears a new recession

New laws in the pipeline

McNeil retains leadership of consumer health

Grocery retailers consolidate trends

Slow movement going forward

KEY TRENDS AND DEVELOPMENTS

Economy fears a new recession

New laws in the pipeline

Climate shapes sales

Spanish population

The silent pandemic

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Penetration of Private Label by Category 2006-2011
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC Registration and Classification

Consumer Health Registration and Classification

Advertising

Packaging and Labelling

Waste

Distribution

Groups and associations for pharmacists grow

De-listing or de-reimbursement

Vitamins and dietary supplements registration and classification

Retail Distribution

Alternative Therapy

Homoeopathic Medicines

Self-medication/self-care and preventative medicine

Switches

DEFINITIONS

SOURCES

  • Summary 1 Research Sources

Consumer Health in Spain - Company Profiles

Almirall Prodesfarma SA in Consumer Health (Spain)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 4 Almirall Prodesfarma SA: Competitive Position 2011

Bayer Hispania SA in Consumer Health (Spain)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 6 Bayer Hispania SA: Competitive Position 2011

Bicentury SL in Consumer Health (Spain)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 9 Bicentury SL: Competitive Position 2011

Boehringer Ingelheim España SA in Consumer Health (Spain)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 12 Boehringer Ingelheim España SA: Competitive Position 2011

Esteve SA in Consumer Health (Spain)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 15 Esteve SA: Competitive Position 2011

Laboratorios Viñas SA in Consumer Health (Spain)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 17 Laboratorios Viñas SA: Competitive Position 2011

McNeil Iberica SLU in Consumer Health (Spain)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 19 McNeil Iberica SLU: Competitive Position 2011

Novartis Farmaceutica SA in Consumer Health (Spain)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 21 Novartis Consumer Health SA: Competitive Position 2011

Rovi SA in Consumer Health (Spain)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Uriach-Aquilea OTC SL in Consumer Health (Spain)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 26 Uriach-Aquilea OTC SL: Competitive Position 2011

Adult Mouth Care in Spain - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care declined by 2% in 2011 with current value sales reaching EUR34 million. Although adult mouth care has the advantage of being almost free from prescription-only products and hence the substitution between OTC and reimbursed references does not take place as in other consumer health categories, adult mouth care suffers from other competition: cosmetic products. Personal care products continued to restrict growth potential. This is especially important in the case of some mouthwash products, sales of which were hampered by the new Listerine.

SWITCHES

COMPETITIVE LANDSCAPE

  • Little excitement took place in Spanish adult mouth care in 2011. Company shares remained steady over the review period. McNeil, after the acquisition of Pfizer healthcare range, consolidated its leading position accounting for 66% share of value sales. This strong position is linked to the performance of Oraldine.

PROSPECTS

  • Sales of adult mouth care products are predicted to drop by 18% overall in constant value terms over the forecast period. The fears that the Spanish recovery is not going to happen in the short- term along with the global fear of a new recession will drag down the performance of adult mouth care.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2006-2011
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 14 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 15 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Spain - Category Analysis

HEADLINES

TRENDS

  • As in 2010, current value sales of analgesics in Spain in 2011 were affected by the poor economic environment. The high unemployment rate, which in 2011 was close to 22%, dragged down Spanish average disposable incomes and as a consequence consumers attempted to save money by using reimbursed products instead of consumer health ones. This was a consequence of the change in shopping habits, with price becoming the key variable taken into account when making a purchasing decision. As a result current value sales of analgesics dropped by 4% to reach EUR257 million.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011, analgesics continued to be led by Bayer Hispania with 14% value share, although it lost one percentage point from 2010. The company continued to suffer from the poor performance of Aspirina, although it remained active in the promotion and advertising of its aspirin products especially focusing on back pain relief.

PROSPECTS

  • In Spanish analgesics, the same active ingredient can be found in both reimbursed and as OTC status, and as the pessimism invades Spanish economic expectations, and consumers decide to save instead of spend, then the number of prescriptions is expected to grow to the detriment of OTC sales. Analgesics is predicted to witness a constant value CAGR of -4% over the forecast period.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2006-2011
  • Table 19 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 21 Analgesics Company Shares by Value 2007-2011
  • Table 22 Analgesics Brand Shares by Value 2008-2011
  • Table 23 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Spain - Category Analysis

HEADLINES

TRENDS

  • Spaniards’ mental health and related problems continued to grow with the economic situation, especially amongst those Spaniards who were made redundant. According to the study carried out by the San Juan de Dios Hospitales, 34% of unemployed Spaniards suffer from depression and anxiety-related problems, whereas only 15% of those Spaniards with a job suffer from these problems. This supported sales of calming and sleeping in Spain which grew by 6% in current value terms in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • No big changes took place in Spanish calming and sleeping in 2011. Sales continued to be dominated by Esteve which consolidated its first position in 2011. However, the company lost ground to its main competitor Solvay Pharma which gained 2.7 percentage points in value share. Solvay’s Valdispert was the best performing calming and sleeping product in 2011 to hold 11% value share.

PROSPECTS

  • As over the review period, sales of calming and sleeping are predicted to be shaped by the economic situation. With the unemployment rate close to 22% and a foreseeable change in the Spanish government which is expected to result in reduced government expenditure, two divergent forces are set to drive this category’s growth. First, Spaniards will try to save money by switching from OTC products to reimbursed ones. Second, the restrictive expenditure policy the government is set to follow over the forecast period in order to satisfy other priorities rather than expenditure on medicine.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2006-2011
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 27 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 28 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Spain - Category Analysis

HEADLINES

TRENDS

  • The virulence of influenza outbreaks – typically one in autumn and another in winter - in 2010 were not significantly different from other years and hence cough and cold sales evolved inline with previous years. During 2010, around 90% of the flu cases were “Gripe A”. Sales of cough, cold and allergy (hay fever) remedies reached EUR388 million.

SWITCHES

COMPETITIVE LANDSCAPE

  • No important changes took place in cough, cold and allergy (hay fever) remedies in Spain in 2011. There are over 30 companies active in the category, making it a highly fragmented environment. As in the previous year, in 2011 Johnson & Johnson subsidiary McNeil Iberica remained the leading company, due to the primary position of its combination product Frenadol.

PROSPECTS

  • The fear of a new global recession is slowing down the recovery of the Spanish economy. International organisations –IMF and ODCE – have already highlighted the fact that the Spanish economy will continue to suffer and that tough measures will need to be taken in order to get the economy back on track. As part of these new measures, the government has changed to a prescription by active ingredient system. This new system, which is already active in one of the Spanish regions, Andalucía, will result in increased importance of generic medicines.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 33 Sales of Decongestants by Category: Value 2006-2011
  • Table 34 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 35 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 36 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Spain - Category Analysis

HEADLINES

TRENDS

  • The latest study carried out by the Spanish laboratory Cinfa, showed that in Spain more than 14 million people suffer from constipation related problems. The poor dietary habits Spaniards are now sharing with their European counterparts, along with the high levels of stress, is leading to an increase in the number of Spaniards suffering from this problem. As a result, and driven by laxatives’ performance, sales of digestive remedies grew by 2% to reach EUR204million.

SWITCHES

COMPETITIVE LANDSCAPE

  • Digestive remedies continued to be characterised by the high degree of concentration. The five leading companies accounted for 73% share of total value sales. In ranking terms, no big changes took place with Almirall remaining as leader in 2011.

PROSPECTS

  • The latest report published by the OECD announced that Spain will take fifteen years to return to the unemployment rates recorded before the economic crisis. This along with the low growth rates expected to be recorded over the forecast period will erode the average Spanish disposable income shaping the overall performance of digestive remedies over the forecast period. Constant value sales of digestive remedies are expected to marginally decline.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 43 Digestive Remedies Company Shares by Value 2007-2011
  • Table 44 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Spain - Category Analysis

HEADLINES

TRENDS

  • 2011 brought about a change in the negative trend of ear care. The intense campaign Centros Gaes carried out on television, casting one of the most loved Spanish actors – Imanol Arias– played a key role in the positive performance of these products. The campaign is trying to make Spaniards more aware of the importance of taking good care of their ears. Sales of ear care increased by 2% in 2011 to reach EUR1.9 million.

SWITCHES

COMPETITIVE LANDSCAPE

  • As in the rest of the review period, in 2011 Teofarma’s Taponoto Gotas remained as the dominant product in ear care, holding a value share of 66%, and will remain so going forward, as it is widely recommended by doctors.

PROSPECTS

  • It is expected that after the promotional campaign by GAES ends, sales of ear care will return to their declining trend over the forecast period. The poor economic framework and the high unemployment rates will result in Spaniards prioritising where to spend their money and OTC products will suffer from their substitution by reimbursed medicines.

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2006-2011
  • Table 48 Sales of Ear Care: % Value Growth 2006-2011
  • Table 49 Ear Care Company Shares by Value 2007-2011
  • Table 50 Ear Care Brand Shares by Value 2008-2011
  • Table 51 Forecast Sales of Ear Care: Value 2011-2016
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2011-2016

Emergency Contraception in Spain - Category Analysis

HEADLINES

TRENDS

  • Current value sales of emergency contraception reached a value of EUR7 million in 2011, growing dynamically by 125% in 2011. Although this represents an important growth rate, it is linked to its low base. Nevertheless, the new law on abortion makes that makes it a service financed by the public health system also influenced sales of emergency contraception.

COMPETITIVE LANDSCAPE

  • The two main companies active in emergency contraception environment in Spain are Chiesi España and Bayer, with the products NorLevo and Postinor, with respective value shares of 61% and 39%. ellaOne by HRA Pharma is also available, although this product claims to be effective in the five days after its intake not as the other two- this product still needs a prescription in the Spanish market.

PROSPECTS

  • The forecast period is set to see sales rise by a constant value CAGR of 8% albeit from a very low base. Emergency contraception’s performance will continue to be dependent on legislation as well as sex education of individuals, as this product is only meant to be administered as a last resort rather than relied upon on a fairly regular basis. Due to the controversial nature of this product, both government and health institutions try to turn the focus away, instead attempting to educate consumers about more traditional contraceptives.

CATEGORY DATA

  • Table 53 Sales of Emergency Contraception: Value 2009-2011
  • Table 54 Sales of Emergency Contraception: % Value Growth 2009-2011
  • Table 55 Emergency Contraception Company Shares by Value 2007-2011
  • Table 56 Emergency Contraception Brand Shares by Value 2008-2011
  • Table 57 Forecast Sales of Emergency Contraception: Value 2011-2016
  • Table 58 Forecast Sales of Emergency Contraception: % Value Growth 2011-2016

Eye Care in Spain - Category Analysis

HEADLINES

TRENDS

  • In 2011, eye care current value sales in Spain were worth EUR32 million, up 3% on 2010.The record of more extreme climate conditions which resulted in not only higher levels of pollen but also in a longer pollination period, definitely influenced the virulence of the allergies in 2011. Traditionally, Spaniards who fight allergy symptoms take allergy remedies; however in 2011 the allergies were so strong that a combination of systemic antihistamines and standard eye care were recommended by most doctors. As a consequence, there was a shift from the poor performance recorded in the previous year.

SWITCHES

COMPETITIVE LANDSCAPE

  • After Johnson & Johnson acquired Pfizer’s healthcare division, Spanish subsidiary McNeil established its leading position in Spanish eye care. The company was responsible for generating 26% share of all value sales. Its leading brand, Vispring, accounts for most of its sales and its good performance in 2011 explains the company’s extraordinary results. The brand’s strong performance is related to the intensive television campaign carried out by the company throughout the year.

PROSPECTS

  • Eye care sales are predicted to grow by 8% overall in constant value terms over the forecast period, a slight improvement compared to review period performance, when sales grew by 6%.

CATEGORY DATA

  • Table 59 Sales of Eye Care by Category: Value 2006-2011
  • Table 60 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 61 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 62 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 63 Eye Care Company Shares by Value 2007-2011
  • Table 64 Eye Care Brand Shares by Value 2008-2011
  • Table 65 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 66 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Spain - Category Analysis

HEADLINES

TRENDS

  • As with the rest of consumer health, the poor economic conditions negatively influenced the performance of herbal/traditional products with sales dropping by 1% in 2011, worsening the performance recorded on the previous year. A more recent study carried out by Infito (the Spanish Association of Herbal Medicines) in 2008 regarding Spanish habits towards herbal products, showed that one in three Spaniards uses herbal products to treat ailments.

COMPETITIVE LANDSCAPE

  • Cadbury consolidated its leading position within Spanish herbal/traditional products in 2011 with 17% value share. The company is active in cough, cold and allergy (hay fever) remedies through its line of medicated confectionery. Cadbury is especially active with its brands Halls and Respiral.

PROSPECTS

  • The fact that the Spanish economic recovery is not foreseeable in the short-term will drag sales of herbal/traditional products. Over the forecast period, it is predicted to record a constant value CAGR of -2%. Until Spain is able to sustain stable employment Spaniards are more likely to go to the doctor to obtain a prescription for the medicine needed instead of getting a full price herbal medicine.

CATEGORY DATA

  • Table 67 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 68 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 69 Herbal/Traditional Products Company Shares 2007-2011
  • Table 70 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 71 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 72 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Spain - Category Analysis

HEADLINES

TRENDS

  • The poor economic conditions experienced in Spain are clearly affecting sales of medicated skin care as they did the rest of Spanish consumer health. Moreover in Spain, in 2011 the number of families with all their members unemployed reached 1,386,000. This fact placed even more pressure on the family budget as traditionally it has been the family network that has absorbed impact of unemployment distress in Spain, as although one member may be unemployed the economic needs of the family unit can be dealt with through other family members who are employed.

SWITCHES

COMPETITIVE LANDSCAPE

  • Private label recorded the best performance in 2011, reaching 7% value share. The market leader Bayer holds greater a great share of 13%, though the company has seen minimal growth in market share. The importance of private label grew throughout the review period. Both the aggressive pricing policies and the strategy of some retailers – such as Mercadona and Carrefour – of reducing their branded products and offering aggressive price campaigns such as “buy one get one half price” or “three for two”, alongside the drop in consumer’s disposable incomes, contributed to private label’s strong performance.

PROSPECTS

  • The gloomy economic expectations along with the high level of uncertainty among the Spanish is set to shape the performance of medicated skin care which is predicted to witness a constant value CAGR of-1. The Spanish government hopes not to share the same fate as Greece, Ireland and Portugal and with that purpose, it will have to take unpopular economic measures such as the new wealth tax that will result in a drop in disposable incomes and as a consequence, reimbursed substitutions and private label products will grow dragging down OTC sales.

CATEGORY DATA

  • Table 73 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 74 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 75 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 76 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 77 Hair Loss Treatments Brand Shares by Value 2008-2011
  • Table 78 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 79 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Spain - Category Analysis

HEADLINES

TRENDS

  • In January 2011, a new and more comprehensive ban on smoking passed by the Spanish government came into force. As occurred with the previous ban on smoking in 2006, current value sales of NRT smoking cessation aids grew strongly in 2011 reaching EUR31 million, which were 9% up on the previous year.

SWITCHES

COMPETITIVE LANDSCAPE

  • In Spain, NRT smoking cessation aids is limited by the importance of prescription products, Zyntabac, from GlaxoSmithKline, the leading prescription product, followed by Pfizer Consumer Healthcare’s Champix, also a prescription-only product. However, Champix’s adverse effects which came to light over the last years of the review period benefited to some extent the performance of consumer health products.

PROSPECTS

  • As witnessed with the previous ban on smoking, sales of NRT smoking aids are set to record important growth rates of the two years after the ban on smoking comes into force. After these two years, sales will return to normal levels. NRT smoking aids is expected to witness a constant value CAGR of 3% over the forecast period.

CATEGORY INDICATORS

  • Table 80 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 81 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 82 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 83 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 84 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 85 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 86 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 87 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Spain - Category Analysis

HEADLINES

TRENDS

  • According to industry sources there are two types of sports nutrition consumers in Spain. Those who consume to supplement their exercise routine and those who consume sports nutrition as part of their daily eating diet. The economic crisis resulted in the latter set of consumers discontinuing their purchase of sports nutrition in order to save money; however these are, according to the same sources, part of the first group of consumers.

COMPETITIVE LANDSCAPE

  • There is consensus among industry experts that the Spanish sports nutrition environment is regional, with few companies operating at a national level. Nevertheless, the fact that some companies such as Nutrition &Santé and Weider Nutrition SL, amongst others, are making their lines of products available through department stores and Decathlon is changing this fact.

PROSPECTS

  • Sales of sport nutrition are not set to recover until the Spanish economy does so. The category is predicted to record a constant value CAGR of -2% over the forecast period. The fact that the Spanish government will need to continue issuing policies to constrain the budget deficit will result in an increase of income taxes and the new wealth tax from 2010 and as a consequence decline in average disposable income will take place. As a consequence, Spaniards will shift their consumption habits purchasing sports nutrition through grocery retailers in order to look for the best value-for-money product.

CATEGORY DATA

  • Table 88 Sales of Sports Nutrition: Value 2006-2011
  • Table 89 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 90 Sports Nutrition Company Shares 2007-2011
  • Table 91 Sports Nutrition Brand Shares 2008-2011
  • Table 92 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 93 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Spain - Category Analysis

HEADLINES

TRENDS

  • The Mediterranean diet continued to be the perfect substitute for the intake of vitamins and dietary supplements, as current value sales continued to stagnate.

Vitamins

Dietary Supplements

COMPETITIVE LANDSCAPE

  • Vitamins and dietary supplements is highly fragmented with more than 40% share of total sales in hands of small regional companies which in most of the cases produce a reduced portfolio.

PROSPECTS

  • The gloomy economic future and the uncertainty about the future of the EU will mean that the recovery of Spanish economy will take place as predicted by the Spanish government. The fact that the average unit price of vitamins and dietary supplements is high and the unemployment rate in Spain will likely surpass 22%, will negatively affect its performance, and witness a constant value CAGR of -2% over the forecast period.

CATEGORY DATA

  • Summary 27 Dietary Supplements: Brand Ranking by Positioning 2011
  • Table 94 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 95 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 96 Dietary Supplements by Positioning 2006-2011
  • Table 97 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 98 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 99 Vitamins Brand Shares by Value 2008-2011
  • Table 100 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 101 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 102 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Spain - Category Analysis

HEADLINES

TRENDS

  • According to the latest study carried out by GlaxoSmithKline and published in February 2011,Spaniards are amongst the Europeans who most desire to lose weight as a New Year’s resolution. In particular, over 80% of Spaniards want to lose weight, and this percentage is even higher when considering only Spanish women. This has prevented weight management from seeing negative growth, though just barely as sales remained stagnant at EUR192 million.

COMPETITIVE LANDSCAPE

  • In 2011, Herbalife ranked first in Spanish weight management, gaining some ground over the previous year.  Herbalife’s strength lies in weight loss supplements – which as a category slowed in 2011. Although there is a common belief that its dependence on direct sales negatively affects the company’s performance, the economic crisis benefited it, resulting in sales growing despite the downward growth of weight loss supplements as a whole.

PROSPECTS

  • Spain will take a long time to get out of the economic crisis; this fact will limit the performance of weight management, with a constant value CAGR of -1% over the forecast period. Two facts are set to shape the category’s performance. First, Spaniards will continue to reduce expenditure on non-essential goods, which will erode the performance of slimming products over the forecast period. Second, the extraordinary success of the Dukan Diet, and expected new diets will negatively impact weight management’s performance. Nevertheless, the importance of self-image will continue be the main driver of sales of weight management products.

CATEGORY DATA

  • Table 103 Sales of Weight Management: Value 2006-2011
  • Table 104 Sales of Weight Management: % Value Growth 2006-2011
  • Table 105 Weight Management Company Shares 2007-2011
  • Table 106 Weight Management Brand Shares 2008-2011
  • Table 107 Forecast Sales of Weight Management: Value 2011-2016
  • Table 108 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Spain - Category Analysis

HEADLINES

TRENDS

  • In 2011, wound care declined by 1% in current value terms to reach EUR22 million. Wound care has responded to strong private label competition in the latter part of the review period. The deep economic crisis in Spain shaped sales of wound care. The drop in the average disposable income resulted in Spaniards devising ways to save money and switching from branded products to private label was one of them.

COMPETITIVE LANDSCAPE

  • As in 2011, private label recorded the best performance, gaining one percentage point in value share by one percentage point, with value sales growing by 7%. The poor economic performance resulted in Spaniards switching their traditional brands from private label which offers the best value-for-money.

PROSPECTS

  • Over the forecast period, wound care is expected to see a -1% constant value CAGR. The increasingly price-competitive presence of private label is expected to undercut value growth for the category, despite on-going product innovation.

CATEGORY DATA

  • Table 109 Sales of Wound Care by Category: Value 2006-2011
  • Table 110 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 111 Wound Care Company Shares by Value 2007-2011
  • Table 112 Wound Care Brand Shares by Value 2008-2011
  • Table 113 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 114 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Artichoke
            • Guarana
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Lecithin
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Paediatric Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Paediatric Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Paediatric Consumer Health
      • Paediatric Analgesics
        • Paediatric Acetaminophen
        • Paediatric Aspirin
        • Paediatric Combination Products - Analgesics
        • Paediatric Diclofenac
        • Paediatric Dipyrone
        • Paediatric Ibuprofen
        • Paediatric Ketoprofen
        • Paediatric Naproxen
      • Paediatric Cough, Cold and Allergy Remedies
        • Paediatric Allergy Remedies
        • Paediatric Cough/Cold Remedies
      • Paediatric Digestive Remedies
        • Paediatric Diarrhoeal Remedies
        • Paediatric Indigestion and Heartburn Remedies
        • Paediatric Laxatives
        • Paediatric Motion Sickness Remedies
      • Paediatric Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Paediatric Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!